Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy?


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
01 02 2023
Historique:
received: 12 12 2022
revised: 17 01 2023
accepted: 30 01 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

α-Synucleinopathies are spreading neurodegenerative disorders characterized by the intracellular accumulation of insoluble aggregates populated by α-Synuclein (α-Syn) fibrils. In Parkinson's disease (PD) and dementia with Lewy bodies, intraneuronal α-Syn aggregates are referred to as Lewy bodies in the somata and as Lewy neurites in the neuronal processes. In multiple system atrophy (MSA) α-Syn aggregates are also found within mature oligodendrocytes (OLs) where they form Glial Cytoplasmic Inclusions (GCIs). However, the origin of GCIs remains enigmatic: (i) mature OLs do not express α-Syn, precluding the seeding and the buildup of inclusions and (ii) the artificial overexpression of α-Syn in OLs of transgenic mice results in a burden of soluble phosphorylated α-Syn but fails to form α-Syn fibrils. In contrast, mass spectrometry of α-Syn fibrillar aggregates from MSA patients points to the neuronal origin of the proteins intimately associated with the fibrils within the GCIs. This suggests that GCIs are preassembled in neurons and only secondarily incorporated into OLs. Interestingly, we recently isolated a synthetic human α-Syn fibril strain (1B fibrils) capable of seeding a type of neuronal inclusion observed early and specifically during MSA. Our goal was thus to investigate whether the neuronal α-Syn pathology seeded by 1B fibrils could eventually be transmitted to OLs to form GCIs in vivo. After confirming that mature OLs did not express α-Syn to detectable levels in the adult mouse brain, a series of mice received unilateral intra-striatal injections of 1B fibrils. The resulting α-Syn pathology was visualized using phospho-S129 α-Syn immunoreactivity (pSyn). We found that even though 1B fibrils were injected unilaterally, many pSyn-positive neuronal somas were present in layer V of the contralateral perirhinal cortex after 6 weeks. This suggested a fast retrograde spread of the pathology along the axons of crossing cortico-striatal neurons. We thus scrutinized the posterior limb of the anterior commissure, i.e., the myelinated interhemispheric tract containing the axons of these neurons: we indeed observed numerous pSyn-positive linear Lewy Neurites oriented parallel to the commissural axis, corresponding to axonal segments filled with aggregated α-Syn, with no obvious signs of OL α-Syn pathology at this stage. After 6 months however, the commissural Lewy neurites were no longer parallel but fragmented, curled up, sometimes squeezed in-between two consecutive OLs in interfascicular strands, or even engulfed inside OL perikarya, thus forming GCIs. We conclude that the 1B fibril strain can rapidly induce an α-Syn pathology typical of MSA in mice, in which the appearance of GCIs results from the pruning of diseased axonal segments containing aggregated α-Syn.

Identifiants

pubmed: 36830639
pii: biom13020269
doi: 10.3390/biom13020269
pmc: PMC9953613
pii:
doi:

Substances chimiques

alpha-Synuclein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Mov Disord. 2013 Nov;28(13):1816-22
pubmed: 23674400
Mol Neurodegener. 2022 Nov 26;17(1):77
pubmed: 36435784
J Neurochem. 2016 Oct;139(2):181-186
pubmed: 27454326
Cell Rep. 2016 Sep 20;16(12):3373-3387
pubmed: 27653697
Neuron. 2006 Oct 5;52(1):33-8
pubmed: 17015225
Neurosci Lett. 2004 Jan 9;354(2):99-102
pubmed: 14698448
Sci Adv. 2020 Oct 2;6(40):
pubmed: 33008896
J Neurosci. 1986 Mar;6(3):650-60
pubmed: 2420946
J Neurol Sci. 1989 Dec;94(1-3):79-100
pubmed: 2559165
Acta Neuropathol Commun. 2021 May 3;9(1):80
pubmed: 33941284
Mol Neurodegener. 2020 Mar 6;15(1):19
pubmed: 32143659
Front Mol Neurosci. 2021 Apr 27;14:607303
pubmed: 33986642
Neuropathol Appl Neurobiol. 2017 Dec;43(7):604-620
pubmed: 28386933
Brain. 2022 Jun 3;145(5):1743-1756
pubmed: 34910119
Neurology. 2007 Mar 13;68(11):812-9
pubmed: 17353469
Mov Disord. 2007 Apr 30;22(6):766-77
pubmed: 17290454
Science. 2012 Nov 16;338(6109):949-53
pubmed: 23161999
EMBO Rep. 2002 Jun;3(6):583-8
pubmed: 12034752
Neuropathology. 2006 Aug;26(4):338-45
pubmed: 16961071
Glia. 2014 Jun;62(6):964-70
pubmed: 24590631
J Comp Neurol. 2019 Apr 1;527(5):985-998
pubmed: 30408165
Mov Disord. 2009 May 15;24(7):949-64
pubmed: 19306362
Acta Neuropathol. 2012 Aug;124(2):153-72
pubmed: 22744791
Nat Neurosci. 2019 Oct;22(10):1696-1708
pubmed: 31551601
Ann Neurol. 1998 Sep;44(3):415-22
pubmed: 9749615
J Neurosci. 2005 Nov 16;25(46):10689-99
pubmed: 16291942
J Neural Transm (Vienna). 2005 Dec;112(12):1613-24
pubmed: 16284907
Neuroscience. 1989;29(3):503-37
pubmed: 2472578
Nat Neurosci. 2022 Mar;25(3):280-284
pubmed: 35241802
Nat Commun. 2013;4:2575
pubmed: 24108358
Sci Rep. 2022 Jan 21;12(1):1163
pubmed: 35064139
Science. 2021 Nov 12;374(6569):eaba6905
pubmed: 34618550
Ann N Y Acad Sci. 2000;920:16-27
pubmed: 11193145
Nat Rev Neurol. 2017 Apr;13(4):232-243
pubmed: 28303913
Proc Natl Acad Sci U S A. 2022 Nov 29;119(48):e2202580119
pubmed: 36417438
J Comp Neurol. 1993 Dec 8;338(2):255-78
pubmed: 8308171
Cells. 2020 Oct 29;9(11):
pubmed: 33138150
Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10369-73
pubmed: 7479786
Neuropathol Appl Neurobiol. 2004 Oct;30(5):546-54
pubmed: 15488031
Nature. 2015 Jun 18;522(7556):340-4
pubmed: 26061766
J Neuropathol Exp Neurol. 2019 Oct 1;78(10):877-890
pubmed: 31504665
Biomolecules. 2022 Mar 24;12(4):
pubmed: 35454083
Neurology. 2005 Dec 27;65(12):1863-72
pubmed: 16237129
Neuropathol Appl Neurobiol. 2007 Feb;33(1):2-42
pubmed: 17239006
Nat Neurosci. 2016 Aug;19(8):1100-14
pubmed: 27322419
Neurobiol Dis. 2015 Feb;74:104-13
pubmed: 25449905
NPJ Parkinsons Dis. 2022 Jan 13;8(1):10
pubmed: 35027576
Cell Res. 2013 Jul;23(7):962-4
pubmed: 23649315
Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):9622-9627
pubmed: 30181276
J Neurol Sci. 1992 Feb;107(2):172-82
pubmed: 1314292
Nature. 2020 Feb;578(7794):273-277
pubmed: 32025029
Biomolecules. 2022 Mar 11;12(3):
pubmed: 35327628
Brain. 2013 Apr;136(Pt 4):1128-38
pubmed: 23466394
Neuron. 2005 Mar 24;45(6):847-59
pubmed: 15797547
Nat Methods. 2012 Jun 28;9(7):690-6
pubmed: 22743774
Stem Cell Reports. 2015 Aug 11;5(2):174-84
pubmed: 26235891
Acta Neuropathol Commun. 2016 Feb 09;4:12
pubmed: 26860328
J Anat. 1987 Feb;150:111-27
pubmed: 3654327
Front Syst Neurosci. 2011 Aug 01;5:64
pubmed: 21866224

Auteurs

Francesco De Nuccio (F)

Department of Biological and Environmental Sciences and Technologies, Section of Human Anatomy, University of Salento, I-73100 Lecce, Italy.

Marianna Kashyrina (M)

Department of Biological and Environmental Sciences and Technologies, Section of Human Anatomy, University of Salento, I-73100 Lecce, Italy.

Francesca Serinelli (F)

Department of Biological and Environmental Sciences and Technologies, Section of Human Anatomy, University of Salento, I-73100 Lecce, Italy.

Florent Laferrière (F)

Institut des Maladies Neurodégénératives, CNRS, Université de Bordeaux, UMR 5293, 33076 Bordeaux, France.

Dario Domenico Lofrumento (DD)

Department of Biological and Environmental Sciences and Technologies, Section of Human Anatomy, University of Salento, I-73100 Lecce, Italy.

Francesca De Giorgi (F)

Institut des Maladies Neurodégénératives, CNRS, Université de Bordeaux, UMR 5293, 33076 Bordeaux, France.

François Ichas (F)

Institut des Maladies Neurodégénératives, CNRS, Université de Bordeaux, UMR 5293, 33076 Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH